Quantcast

Latest Clinical trial Stories

2014-05-23 04:20:51

BLUE BELL, Pa., May 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's shareholders approved the proposal of a reverse split of the Company's common stock. The Company's Board of Directors subsequently approved the immediate implementation of a 1-for-4 reverse stock split of Inovio's common stock, where each 4 shares of issued and outstanding common stock and equivalents...

2014-05-22 23:11:58

Researchers, pharmaceutical companies, advocacy organizations and healthcare providers can access large sets of patient-provided de-identified data to speed research. San Mateo, Calif. (PRWEB) May 22, 2014 PatientCrossroads, pioneer of the groundbreaking CONNECT patient registry platform, has expanded the open availability of disease-specific patient data with the launch of its CONNECT Data Portal. The Data Portal allows any authorized user to see the de-identified patient data that has...

2014-05-22 23:04:58

RnRMarketResearch.com adds “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014” to its store. Order a purchase copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=179159. Dallas, Texas (PRWEB) May 22, 2014 This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...

2014-05-22 08:31:11

SAN FRANCISCO, May 22, 2014 /PRNewswire/ -- PULSE enables highly customized IRT trial design while maintaining endpoint's signature 30-Day delivery timeline endpoint Clinical, Inc., a leading provider of Interactive Response Technology (IRT) systems via phone (IVRS), web (IWRS) and mobile (IMRS) for global clinical trials, today announced the launch of its next-generation PULSE 3.0 platform. The enhanced PULSE platform provides highly customized configuration and...

2014-05-21 13:45:48

American Thoracic Society Reminders prompting asthma patients to take their control inhalers if they miss a dose significantly improve medication adherence, according to a primary-care based study conducted by a research team in Australia. In this six-month investigation, patients receiving reminders took on average 73% of their prescribed doses compared to only 46% in patients who did not have reminders. The results of the cluster randomized controlled trial were presented at the ATS...

2014-05-21 08:29:59

RYE, N.Y., May 21, 2014 /PRNewswire/ -- Curemark, a leading drug research and development company focused on the treatment of neurological and other diseases, announced today that the company was named a Red Herring Top 100 North American award-winner. "We believe that Curemark embodies the vision, drive, and innovation that define a successful entrepreneurial venture. Curemark should be proud of its accomplishment as the competition was very strong," stated Alex Vieux, published...

2014-05-21 08:29:17

- On Track for Study Participation in Major HCC Markets Worldwide - LAWRENCEVILLE, N.J., May 21, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced it has received regulatory clearance to initiate its Phase III OPTIMA Study at clinical trial sites in Taiwan, Hong Kong, South Korea and Canada. The OPTIMA Study is the Company's planned global pivotal, double-blind, placebo-controlled study evaluating ThermoDox®, its proprietary heat-activated liposomal...

2014-05-20 23:09:37

Premier Research presents an exciting live webinar on Tuesday, June 10, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1) examining the trial subject’s knowledge during Neuropsychiatric clinical trials. Toronto, Canada (PRWEB) May 20, 2014 From the imperative to detect cognitive and functional changes as early as possible in the course of Alzheimer’s disease, through the importance of measuring cognitive and attentional effects of investigational drugs in clinical trials, to the...

2014-05-20 20:22:05

VANCOUVER, British Columbia and MENLO PARK, Calif., May 20, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided a quarterly update and a summary of progress toward the Company's goals for the year. DelMar also announced an investor conference call to take place on Thursday June 5, 2014 at 11:30 am EDT. Details and log-in information will be posted on the website at www.delmarpharma.com in advance of the call. Highlights from the...

2014-05-20 16:27:10

- Pooled Efficacy Analyses from Phase 3 ASCEND and CAPACITY Studies Presented at 2014 American Thoracic Society Meeting - SAN DIEGO, May 20, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that results of analyses of pooled data from the ASCEND trial and the two previous Phase 3 CAPACITY trials evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were presented at the 2014 International Conference of the American Thoracic Society (ATS) in San Diego,...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.